Clorox (NYSE:CLX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday.
A number of other research firms have also recently weighed in on CLX. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Evercore ISI lowered their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and lifted their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. DA Davidson boosted their price target on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Finally, Barclays raised their price objective on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research note on Friday, November 1st. Five equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus target price of $155.38.
Clorox Trading Down 0.6 %
Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.49 EPS. Equities research analysts expect that Clorox will post 6.85 EPS for the current year.
Institutional Investors Weigh In On Clorox
A number of hedge funds and other institutional investors have recently modified their holdings of CLX. Prospera Private Wealth LLC acquired a new stake in Clorox during the third quarter worth approximately $27,000. Continuum Advisory LLC boosted its holdings in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the last quarter. Innealta Capital LLC purchased a new stake in shares of Clorox in the second quarter valued at $30,000. Trifecta Capital Advisors LLC increased its stake in Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares during the last quarter. Finally, Quarry LP lifted its position in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after buying an additional 114 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- How to Buy Cheap Stocks Step by Step
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- The Risks of Owning Bonds
- These 3 Quirky ETFs May Be Strong Plays in 2025
- Short Selling: How to Short a Stock
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.